Putative protein product of HMFN1045 (253-264)

Putative protein product of HMFN1045 (253-264) is a synthetic peptide corresponding to amino acid residues 253 through 264 of the hypothetical protein encoded by the HMFN1045 gene. As a defined sequence fragment, it serves as a valuable molecular tool for probing the structural and functional properties of the parent protein. Peptides derived from putative or uncharacterized proteins are increasingly important in exploratory proteomics and functional genomics, offering researchers the ability to dissect specific regions of larger proteins for mechanistic studies. The unique sequence of this peptide fragment provides opportunities to investigate conserved motifs, potential post-translational modification sites, and protein-protein interaction domains, thereby supporting a wide range of biochemical and molecular biology applications.

Epitope mapping: Synthetic peptides such as this fragment are frequently employed to identify linear B-cell or T-cell epitopes within larger protein contexts. By using the HMFN1045 (253-264) peptide in immunoassays, researchers can screen for antibody recognition sites, facilitating the development of specific antibodies against the parent protein. This approach is instrumental in generating reagents for immunodetection, western blotting, or immunoprecipitation, particularly when the full-length protein is difficult to express or purify.

Protein-protein interaction studies: The defined sequence of the HMFN1045 (253-264) peptide enables targeted investigation of protein binding domains. In pull-down assays or surface plasmon resonance experiments, this peptide can be used as a bait to identify interaction partners within cellular extracts or purified systems. Such studies help elucidate the molecular networks in which the parent protein participates, advancing understanding of cellular pathways and regulatory mechanisms.

Post-translational modification analysis: Short synthetic peptides are ideal substrates for in vitro enzymatic assays to examine potential modification sites, such as phosphorylation, acetylation, or ubiquitination. The HMFN1045 (253-264) fragment can be incubated with modifying enzymes or cell lysates to assess site-specific modifications, providing insight into regulatory control points and functional consequences within the context of the full-length protein.

Antibody production: Peptide antigens derived from unique or conserved regions of proteins are commonly used to generate polyclonal or monoclonal antibodies. The HMFN1045 (253-264) sequence, when conjugated to a suitable carrier protein, can elicit a targeted immune response in host animals, resulting in antibodies that specifically recognize the corresponding epitope. These antibodies are essential tools for detection, quantification, and localization of the native protein in various biological samples.

Functional assays: Synthetic peptides serve as valuable reagents in cell-based or biochemical assays designed to probe the activity of the parent protein or its interacting partners. The HMFN1045 (253-264) fragment can be introduced into experimental systems to assess its influence on cellular processes, signal transduction events, or enzymatic activities. By mimicking a specific region of the full-length protein, such peptides enable detailed structure-activity relationship studies and facilitate the functional characterization of previously uncharacterized proteins.

1. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis

2. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry

3. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function

4. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists

5. C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients